Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07129291

Development of Dual Language (Urdu and English) Digital Software for SA, Management Of Adult Dysarthria

The research focuses on the development of a dual-language (Urdu and English) digital software designed for the self-assessment and management of adult dysarthria patients. Dysarthria, a motor speech disorder resulting from neurological injury, significantly affects an individual's ability to communicate effectively.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Rehabilitation Centers in Punjab

Lahore, Punjab Province, Pakistan

About this study

Current assessment tools are often clinician-dependent and predominantly available in English, limiting accessibility for non-English speakers, especially in Pakistan and other Urdu-speaking regions. This study aims to bridge that gap by creating a user-friendly, culturally relevant, and linguistically accessible software platform. The software will enable adult dysarthric patients to monitor their speech abilities, track progress, and participate more actively in their therapy process. It is expected to enhance patient autonomy, improve communication outcomes, and support speech-language pathologists in delivering more efficient care. The dual-language interface ensures broader usability, promoting inclusion and better engagement among diverse user groups in bilingual settings.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults (18+) diagnosed with dysarthria due to neurological causes (e.g., stroke, Parkinson's).
  • Able to understand and communicate in Urdu and/or English.
  • Cognitive ability sufficient to use digital tools for self-assessment.
  • Consent to participate in the study.

Exclusion criteria

  • Severe cognitive impairment or dementia limiting participation.
  • Co-existing speech disorders unrelated to dysarthria (e.g., aphasia).
  • Hearing impairments that prevent use of audio-based software.
  • Unwillingness or inability to use digital devices.

Treatment and study plan

Experimental: Dual-Language Dysarthria Self-Assessment and Management Software (D-SAMS)

Combination Product

D-SAMS is a bilingual (Urdu and English) digital tool designed for adult dysarthria patients. It enables users to assess their speech through interactive tasks (e.g., repetition, reading, and pronunciation exercises), receive feedback, and track progress over time. The software includes audio-visual prompts, self-rating scales, and progress charts, and is tailored to accommodate varying levels of dysarthria severity. It supports independent practice and helps speech-language pathologists monitor patients remotely

Primary outcomes

  1. Frenchay Dysarthria Assessment (FDA-2)

    Time frame: 24 Months

    Assesses: Motor speech function. Scoring: A (normal) to E (severely impaired) across speech subsystems.

  2. Dysarthria Impact Profile (DIP)

    Time frame: 24 Months

    Assesses: Psychosocial impact of dysarthria. Scoring: 48 items, rated 1-5; higher scores = greater negative impact.

  3. Speech Intelligibility Rating Scale (SIRS)

    Time frame: 24 Months

    Assesses: Speech clarity. Scoring: 1 (unintelligible) to 5 (fully intelligible).

  4. Voice Handicap Index-10 (VHI-10) (optional)

    Time frame: 24 Months

    Assesses: Patient's perception of voice issues. Scoring: 0-4 per item; total out of 40. Higher = more voice difficulty.

Sponsors and collaborators

Lead sponsor

Superior University

Other

Registry information

Official study title

Development of Dual Language (Urdu and English) Digital Software For Self- Assessment And Management Of Adult Dysarthria Patients

Important dates

Study start
2025
Primary completion
2026
Study completion
2027
First posted
Aug 19, 2025
Registry last updated
Aug 19, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.